Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.
Formalin-fixed, paraffin-embedded (FFPE) tissues are an underused resource for molecular analyses. This proof of concept study aimed to compare RNAseq results from FFPE biopsies with the corresponding RNAlater® (Qiagen, Germany) stored samples from clear cell renal cell carcinoma (ccRCC) patients to...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4764764?pdf=render |
| _version_ | 1818322047927844864 |
|---|---|
| author | Oystein Eikrem Christian Beisland Karin Hjelle Arnar Flatberg Andreas Scherer Lea Landolt Trude Skogstrand Sabine Leh Vidar Beisvag Hans-Peter Marti |
| author_facet | Oystein Eikrem Christian Beisland Karin Hjelle Arnar Flatberg Andreas Scherer Lea Landolt Trude Skogstrand Sabine Leh Vidar Beisvag Hans-Peter Marti |
| author_sort | Oystein Eikrem |
| collection | DOAJ |
| description | Formalin-fixed, paraffin-embedded (FFPE) tissues are an underused resource for molecular analyses. This proof of concept study aimed to compare RNAseq results from FFPE biopsies with the corresponding RNAlater® (Qiagen, Germany) stored samples from clear cell renal cell carcinoma (ccRCC) patients to investigate feasibility of RNAseq in archival tissue. From each of 16 patients undergoing partial or full nephrectomy, four core biopsies, such as two specimens with ccRCC and two specimens of adjacent normal tissue, were obtained with a 16g needle. One normal and one ccRCC tissue specimen per patient was stored either in FFPE or RNAlater®. RNA sequencing libraries were generated applying the new Illumina TruSeq® Access library preparation protocol. Comparative analysis was done using voom/Limma R-package. The analysis of the FFPE and RNAlater® datasets yielded similar numbers of detected genes, differentially expressed transcripts and affected pathways. The FFPE and RNAlater datasets shared 80% (n = 1106) differentially expressed genes. The average expression and the log2 fold changes of these transcripts correlated with R2 = 0.97, and R2 = 0.96, respectively. Among transcripts with the highest fold changes in both datasets were carbonic anhydrase 9 (CA9), neuronal pentraxin-2 (NPTX2) and uromodulin (UMOD) that were confirmed by immunohistochemistry. IPA revealed the presence of gene signatures of cancer and nephrotoxicity, renal damage and immune response. To simulate the feasibility of clinical biomarker studies with FFPE samples, a classifier model was developed for the FFPE dataset: expression data for CA9 alone had an accuracy, specificity and sensitivity of 94%, respectively, and achieved similar performance in the RNAlater dataset. Transforming growth factor-ß1 (TGFB1)-regulated genes, epithelial to mesenchymal transition (EMT) and NOTCH signaling cascade may support novel therapeutic strategies. In conclusion, in this proof of concept study, RNAseq data obtained from FFPE kidney biopsies are comparable to data obtained from fresh stored material, thereby expanding the utility of archival tissue specimens. |
| first_indexed | 2024-12-13T10:50:36Z |
| format | Article |
| id | doaj.art-90a738f0052d4d878e7e4a8672f0950a |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-13T10:50:36Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-90a738f0052d4d878e7e4a8672f0950a2022-12-21T23:49:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014974310.1371/journal.pone.0149743Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.Oystein EikremChristian BeislandKarin HjelleArnar FlatbergAndreas SchererLea LandoltTrude SkogstrandSabine LehVidar BeisvagHans-Peter MartiFormalin-fixed, paraffin-embedded (FFPE) tissues are an underused resource for molecular analyses. This proof of concept study aimed to compare RNAseq results from FFPE biopsies with the corresponding RNAlater® (Qiagen, Germany) stored samples from clear cell renal cell carcinoma (ccRCC) patients to investigate feasibility of RNAseq in archival tissue. From each of 16 patients undergoing partial or full nephrectomy, four core biopsies, such as two specimens with ccRCC and two specimens of adjacent normal tissue, were obtained with a 16g needle. One normal and one ccRCC tissue specimen per patient was stored either in FFPE or RNAlater®. RNA sequencing libraries were generated applying the new Illumina TruSeq® Access library preparation protocol. Comparative analysis was done using voom/Limma R-package. The analysis of the FFPE and RNAlater® datasets yielded similar numbers of detected genes, differentially expressed transcripts and affected pathways. The FFPE and RNAlater datasets shared 80% (n = 1106) differentially expressed genes. The average expression and the log2 fold changes of these transcripts correlated with R2 = 0.97, and R2 = 0.96, respectively. Among transcripts with the highest fold changes in both datasets were carbonic anhydrase 9 (CA9), neuronal pentraxin-2 (NPTX2) and uromodulin (UMOD) that were confirmed by immunohistochemistry. IPA revealed the presence of gene signatures of cancer and nephrotoxicity, renal damage and immune response. To simulate the feasibility of clinical biomarker studies with FFPE samples, a classifier model was developed for the FFPE dataset: expression data for CA9 alone had an accuracy, specificity and sensitivity of 94%, respectively, and achieved similar performance in the RNAlater dataset. Transforming growth factor-ß1 (TGFB1)-regulated genes, epithelial to mesenchymal transition (EMT) and NOTCH signaling cascade may support novel therapeutic strategies. In conclusion, in this proof of concept study, RNAseq data obtained from FFPE kidney biopsies are comparable to data obtained from fresh stored material, thereby expanding the utility of archival tissue specimens.http://europepmc.org/articles/PMC4764764?pdf=render |
| spellingShingle | Oystein Eikrem Christian Beisland Karin Hjelle Arnar Flatberg Andreas Scherer Lea Landolt Trude Skogstrand Sabine Leh Vidar Beisvag Hans-Peter Marti Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development. PLoS ONE |
| title | Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development. |
| title_full | Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development. |
| title_fullStr | Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development. |
| title_full_unstemmed | Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development. |
| title_short | Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development. |
| title_sort | transcriptome sequencing rnaseq enables utilization of formalin fixed paraffin embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development |
| url | http://europepmc.org/articles/PMC4764764?pdf=render |
| work_keys_str_mv | AT oysteineikrem transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT christianbeisland transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT karinhjelle transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT arnarflatberg transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT andreasscherer transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT lealandolt transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT trudeskogstrand transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT sabineleh transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT vidarbeisvag transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment AT hanspetermarti transcriptomesequencingrnaseqenablesutilizationofformalinfixedparaffinembeddedbiopsieswithclearcellrenalcellcarcinomaforexplorationofdiseasebiologyandbiomarkerdevelopment |